Ahrens Investment Partners’s Biogen BIIB Stock Holding History

Ahrens Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$203K	Hold	730	–	–	0.1%	140
2022 Q4	$202K	Buy	+730	New	+$206K	0.09%	157
2022 Q3	–	Sell	-730	Closed	-$149K	–	238
2022 Q2	$149K	Hold	730	–	–	0.07%	187
2022 Q1	$154K	Sell	730 -10	-1%	-$2.17K	0.05%	213
2021 Q4	$178K	Hold	740	–	–	0.08%	201
2021 Q3	$209K	Hold	740	–	–	0.1%	193
2021 Q2	$256K	Hold	740	–	–	0.12%	186
2021 Q1	$207K	Buy	+740	New	+$200K	0.1%	188
2020 Q4	–	Sell	-805	Closed	-$228K	–	191
2020 Q3	$228K	Hold	805	–	–	0.15%	137
2020 Q2	$215K	Sell	805 -15	-2%	-$4.51K	0.13%	142
2020 Q1	$259K	Hold	820	–	–	0.19%	91
2019 Q4	$243K	Buy	+820	New	+$228K	0.1%	138
2019 Q1	–	Sell	-790	Closed	-$238K	–	174
2018 Q4	$238K	Sell	790 -190	-19%	-$60.6K	0.11%	125
2018 Q3	$346K	Buy	980 +45	+5%	+$15.5K	0.13%	112
2018 Q2	$271K	Sell	935 -7	-0.7%	-$1.97K	0.11%	121
2018 Q1	$258K	Buy	942 +2	+0.2%	+$621	0.11%	113
2017 Q4	$299K	Hold	940	–	–	0.12%	104
2017 Q3	$294K	Hold	940	–	–	0.13%	97
2017 Q2	$255K	Hold	940	–	–	0.11%	110
2017 Q1	$257K	Hold	940	–	–	0.12%	105
2016 Q4	$267K	Buy	+940	New	+$279K	0.14%	102

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ahrens Investment Partners's BIIB Position: Q1 2023 in Review

Ahrens Investment Partners held its Biogen (BIIB) position steady in Q1 2023 at 730 shares worth $203K. The position accounts for 0.1% of the portfolio, ranked #140.

Ahrens Investment Partners first reported a position in BIIB in Q4 2016 and has held it in 21 quarters since. The position peaked at $346K in Q3 2018. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

Ahrens Investment Partners held 730 shares of Biogen worth $203K as of Q1 2023.
Ahrens Investment Partners left its Biogen share count unchanged in Q1 2023.
Biogen made up 0.1% of Ahrens Investment Partners's portfolio in Q1 2023, its #140 holding.
Ahrens Investment Partners first reported a position in Biogen in Q4 2016 and has held it in 21 quarters since.
Ahrens Investment Partners's Biogen position peaked at $346K in Q3 2018.
1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.